Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Institute of Medicine, Denise Caruso, Board on Health Sciences Policy
Details
- OL Work ID
- OL39657846W
Subjects
Pharmaceutical policyDrugs, law and legislationDrugs, testing